Cargando…
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma
KDM4C, which is a histone lysine demethylase, has been proposed to participate in the malignant transformation and progression of several types of cancer. However, its roles in hepatocellular carcinoma (HCC) remain poorly understood. Here, we find that KDM4C protein expression is increased in HCC an...
Autores principales: | Zeng, Zhen, Li, Zixuan, Xue, Jun, Xue, Huichan, Liu, Zhiwei, Zhang, Wenxuan, Liu, Hongli, Xu, Shuangbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147924/ https://www.ncbi.nlm.nih.gov/pubmed/37117173 http://dx.doi.org/10.1038/s41420-023-01418-w |
Ejemplares similares
-
Targeting KDM4C enhances CD8(+) T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer
por: Jie, Xiaohua, et al.
Publicado: (2022) -
KDM2B regulates hippocampal morphogenesis by transcriptionally silencing Wnt signaling in neural progenitors
por: Zhang, Bo, et al.
Publicado: (2023) -
β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma
por: Lu, Yanwei, et al.
Publicado: (2021) -
RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A
por: Chen, Dong-Bo, et al.
Publicado: (2020) -
KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation
por: Ma, Yu‐Shui, et al.
Publicado: (2021)